Release Date: 22/08/13 14:57 Summary: Appendix 3B Exercise Options, Vest and lapse of PSRs Price Sensitive: No Download Document 156.26KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%